Amicus Therapeutics Inc (FOLD)
10.28
+0.10
(+1.03%)
USD |
NASDAQ |
Apr 26, 16:00
10.28
0.00 (0.00%)
After-Hours: 16:03
Amicus Therapeutics Gross Profit Margin (Quarterly): 90.16% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.16% |
| September 30, 2023 | 90.39% |
| June 30, 2023 | 90.36% |
| March 31, 2023 | 91.95% |
| December 31, 2022 | 89.35% |
| September 30, 2022 | 83.55% |
| June 30, 2022 | 89.85% |
| March 31, 2022 | 90.37% |
| December 31, 2021 | 90.44% |
| September 30, 2021 | 85.30% |
| June 30, 2021 | 89.17% |
| March 31, 2021 | 90.15% |
| December 31, 2020 | 86.66% |
| September 30, 2020 | 87.55% |
| June 30, 2020 | 89.29% |
| Date | Value |
|---|---|
| March 31, 2020 | 89.17% |
| December 31, 2019 | 87.44% |
| September 30, 2019 | 88.53% |
| June 30, 2019 | 87.84% |
| March 31, 2019 | 88.09% |
| December 31, 2018 | 86.69% |
| September 30, 2018 | 79.07% |
| June 30, 2018 | 85.29% |
| March 31, 2018 | 84.34% |
| December 31, 2017 | 82.28% |
| September 30, 2017 | 83.54% |
| June 30, 2017 | 85.18% |
| March 31, 2017 | 81.41% |
| December 31, 2016 | 82.73% |
| September 30, 2016 | 83.83% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
83.55%
Minimum
Sep 2022
91.95%
Maximum
Mar 2023
88.82%
Average
89.29%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
| TG Therapeutics Inc | 82.14% |
| Geron Corp | -- |
| Vanda Pharmaceuticals Inc | 92.36% |
| Fate Therapeutics Inc | -- |
| Editas Medicine Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -120.2% |
| Return on Assets | -20.50% |
| Return on Invested Capital | -29.26% |
| Profit Margin (Quarterly) | -29.41% |
| Operating Margin (Quarterly) | -3.21% |
| Return on Net Operating Assets | -38.40% |